Despite over 50 years of research, ASCVD remains the leading cause of mortality worldwide and is associated with a huge economic burden (0.7% of global GDP, to be exact). Worryingly, prevalence continues to rise, particularly in those aged under 50.
After more than 26 years in the industry, why do I still find it hard to explain what I do? Probably because of the variety, the pace of change, and the fact that I still feel I've got a lot to learn. For #MedCommsDay, I've had a proper go at answering.
Two finger wags in a week?! It’s Monday morning and perched at the top of my inbox is MM&M’s daily newsletter with a subject line so intriguing I can’t help but take notice.
I love publications. I love writing them, I love reading them. I don’t want artificial intelligence (AI) to write a publication for me – I want to write it myself.
Have you ever found yourself going down a rabbit hole of scientific articles, just because you love learning? Do you get excited about the latest medical breakthroughs, even if they aren’t in your specific field? If so, you’re not alone. Many of us in MedComms are driven by an insatiable curiosity –
www.LinkedIn.com. Enter email. Enter password. Sign in. Oh look, an AI-generated blister pack toy version of that recruiter I spoke to 5 years ago!Oh, and another!Oh… another.Oh.
Life is built upon the principle of chirality, the property of asymmetry where molecules, much like left and right hands, cannot be superimposed on their mirror images.1,2 Living organisms almost always use one specific form of these chiral molecules: nearly all amino acids are left-handed, while DN
At the end of January, I was fortunate enough to attend the 2025 European Meeting of the ISMPP (International Society for Medical Publication Professionals) in London. This year’s 2-day meeting was the biggest yet, with around 420 attendees. Those of us with the Certified Medical Publication Profess
AI seems to be everywhere nowadays, doesn’t it? From healthcare to daily work tasks, the effects of AI are growing and evolving at an incredible pace. Many industries are already reshaping their workflows, and AI continues to push us forward week by week.
As we step into 2025, the MedComms landscape continues to evolve, with steady advancements shaping how we engage and communicate. Is this the year that AI moves beyond potential and really makes a difference? Will we transform our awareness of sustainability into meaningful action?
During my daily descent down the YouTube rabbit hole, I stumbled upon an ad featuring a teary-eyed, trembling-voiced, menopausal woman. What could be the cause of her upset? Could it be that she is among the 70% of menopausal women who suffer from depression and anxiety?
Parts 1 and 2 of this series dealt with the discovery of hybrid antibodies: fusion receptor-antibody molecules that gain reactivity against a pathogen by integrating a component of a receptor targeted by that selfsame pathogen.1,2 Although hybrid antibodies are unlikely to play a major role in most
